TCBI TEXAS CAPITAL BANCSHARES INC/TX Insider Trading

TCBI CEO Rob C Holmes sold 98,600 shares for $10,012,698.00 across two days; post-sale holdings 167,635 shares (-37.0%)

Rob C Holmes, Chairman, President and CEO of TEXAS CAPITAL BANCSHARES INC/TX, executed two separate sales totaling 98,600 shares for $10,012,698.00 at a blended average price of $101.55 on 2026-06-05 and 2026-06-08. The sales reduced his holdings from 266,235 shares to 167,635 shares, representing a net change of -37.0% versus pre-transaction holdings. The company's fundamentals show annual revenue growth of -37.4% against net income of $73,788,000.00 and a P/E of 12.31, while the stock has declined 7.6% from its 52-week high of $108.92 to the current price of $100.60. The sale by the CEO of a substantial portion of his equity stake occurs against a backdrop of significant revenue contraction year-over-year.

Director Paola M Arbour buys 1,000 shares of TCBI at $91.50; holdings rise 17.6% to 6,671 shares.

Director Paola M Arbour purchased 1,000 shares of TEXAS CAPITAL BANCSHARES INC/TX at $91.50, increasing her holdings by 17.6% from 5,671 to 6,671 shares. The transaction occurred when the stock is trading -12.9% from its 52-week high of $105.98 and down -11.2% over the prior 30 days, suggesting the purchase came during a period of weakness. However, the company faces headwinds: annual revenue contracted -37.4% year-over-year, raising questions about underlying business fundamentals despite a low P/E of 7.37. Against this mixed context—depressed price action and deteriorating top-line growth—the director's open-market purchase warrants monitoring for signal reliability, given her prior cross-ticker sells have posted a 0.00% well-timed rate (90-day returns after prior sells averaged +10.4%, indicating her historical sell exits were poorly timed).

Director Stallings purchases 28,330 shares across 3 transactions (blended avg $30.77) totaling $871,733.80

Director Robert W Stallings acquired 28,330 shares through 3 separate open-market purchases on 2026-02-27 and 2026-03-02 at prices ranging from $22.22 to $94.86, expanding his holdings by +37.2% from 76,257 to 104,587 shares. The mixed price points—particularly the large 20,000-share block at $22.22 on 2026-03-02, well below the higher-priced earlier transactions—suggest opportunistic accumulation across a price range rather than a single conviction-timed entry. His cross-ticker track record shows 20 prior buys with 100% 90-day win rate and +345.4% average 90-day return; however, his 5 prior TCBI trades all remain within measurement windows too recent (2026-02-17 through 2026-03-03) for 90-day outcomes to be available. The current stock price of $95.53 sits 9.9% below the 52-week high of $105.98 and has declined 5.6% over the prior 30 days, placing the purchases within a recent downturn.

Director Whitley purchases 1,000 shares ($97.5K) in TCBI across 2 transactions; stock near 52-week highs (+4.1% YTD).

Director Laura L Whitley executed 2 separate purchases totaling 1,000 shares for $97,535.00 at an average price of $97.54, increasing her holdings by 14.4% from 6,961 to 7,961 shares. The purchases occurred at prices near the 52-week high of $102.28 (current price $97.63 is -4.6% from that peak) and follow a period of positive 30-day (+4.1%) and 90-day (+17.2%) price appreciation. Her cross-ticker track record shows mixed results (50% 90-day win rate, +4.8% average 90-day return) and her TCBI-specific history is split: a 2024 buy underperformed at 90 days (-3.9%) while a 2023 buy outperformed (+13.6%), reflecting inconsistent timing at this ticker. The company faces headwinds with -37.4% annual revenue decline year-over-year, though the valuation appears moderate at P/E 14.81 with $105.2M net income.

TCBI Director Stallings buys 5,000 shares at $67.76; stock down 23.6% from 52-week high amid -37.4% revenue decline

Director Robert W. Stallings purchased 5,000 shares of Texas Capital Bancshares at $67.76 on 2025-04-25, increasing his position to 90,039 shares. This represents his fourth consecutive buy in late April at TCBI, following purchases on 2025-04-21 and 2025-04-23. The purchase occurs while the stock trades 23.6% below its 52-week high and has declined 7.2% over the prior 30 days and 12.8% over 90 days. Fundamentally, TCBI faces headwinds: annual revenue contracted 37.4% year-over-year, and the stock trades at a 32.01 P/E despite net income of $47.0M. The insider's cross-ticker track record shows a 83.33% 90-day win rate with average 90-day returns of +209.0%, but his same-ticker history at TCBI—five consecutive buys in a 9-day window—remains unresolved and cannot yet validate timing accuracy at this specific security.

Director Stallings buys 1,500 shares in 2 transactions at TCBI for $53,900; stock down 11.2% in 30d, 11.9% in 90d.

Director Robert W. Stallings purchased 1,500 shares (500 at $68.20, 1,000 at $19.80) on 2025-04-23, adding 0.7% to his holdings of 228.9K shares. The blended average purchase price of $35.93 falls well below the current price of $68.21, though the stock has declined 11.2% in 30 days and 11.9% in 90 days from recent levels, standing 23.9% below its 52-week high. Stallings' cross-ticker track record shows strong returns (avg 30d +240.1%, 90d +251.0%, 85.71% win rate), but his prior trades at TCBI (5 total including this purchase) show mixed results with recent 30-day returns of +204.0%, +211.6%, and +226.1%, though no 90-day outcomes yet measurable. The company faces headwinds with annual revenue down 37.4%, a high P/E of 31.87, and elevated valuation relative to recent price movement, warranting closer examination of the transaction context and company fundamentals.

Director Robert Stallings purchases 14,000 shares ($471.3K) in 2 tranches at $64.27 and $19.17 on 2025-04-21

Director Robert W. Stallings executed 2 separate purchases totaling 14,000 (14.0K shares) for $471,330.00, increasing his holdings by 6.5% to 227.9K shares. The transactions occurred at substantially different prices ($64.27 and $19.17), yielding a blended average of $33.67. His cross-ticker track record shows 20 prior buys with a 100.00% 90-day win rate and +308.6% average 90-day return, but at TCBI specifically, his 5 prior trades remain early-stage (3 show +200%+ 30-day gains, but 90-day outcomes are not yet measurable). Current stock price of $67.19 stands -25.1% from the 52-week high and -13.5% from 30 days ago, amid headwinds including -37.4% annual revenue growth. The timing and magnitude of this accumulation warrant monitoring against the stock's recent weakness and valuation metrics.

Director Robert W. Stallings bought 7,676 shares in 3 transactions for $198,597.44; prior trades at TCBI show 100% 90-day win rate.

Robert W. Stallings, a director at Texas Capital Bancshares, executed 3 separate open-market purchases totaling 7,676 shares (7.7K shares) for $198,597.44, increasing his holdings by 4.4% to 182,899 shares. His prior 5 trades at TCBI all achieved positive 90-day returns, with a timing pattern of 5 of 5 buys well-timed at the 90-day mark. However, the company is facing material headwinds: net income is reported at $-61,319,000.00 ($-61.3M), annual revenue growth is -37.4%, and the P/E ratio stands at 134.19, reflecting significant earnings pressure. The stock is currently trading at $77.83, down 13.2% from its 52-week high of $89.68, while the blended purchase average was $25.87 across the three transactions—a substantial variance that reflects purchases at significantly lower prices in two of the three transactions. Investors should examine whether these purchases reflect confidence grounded in known operational recovery catalysts or occur against a backdrop of deteriorating fundamentals that warrant scrutiny.